SCA
ADVM

Secor Capital Advisors’s Adverum Biotechnologies ADVM Stock Holding History

Secor Capital Advisors’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,772
Closed -$169K – 593
2015
Q4 		$169K Sell
1,772
-1,653
-48% -$145K 0.05% 484
2015
Q3 		$282K Buy
+3,425
New +$438K 0.09% 368
2015
Q2 		– Sell
-520
Closed -$211K – 413
2015
Q1 		$211K Buy
+520
New +$220K 0.08% 387

Other funds holding ADVM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Secor Capital Advisors's ADVM Position: Q1 2016 in Review

Secor Capital Advisors sold out of Adverum Biotechnologies (ADVM) in Q1 2016, closing a stake of 1,772 shares — an estimated $169K sold.

Secor Capital Advisors first reported a position in ADVM in Q1 2015 and held it in 3 quarters. The position peaked at $282K in Q3 2015. 82 funds tracked by Wall St. Rank hold ADVM as of Q1 2016.

  • Secor Capital Advisors reported no remaining Adverum Biotechnologies position as of Q1 2016 after selling out during the quarter.
  • Secor Capital Advisors sold 1,772 Adverum Biotechnologies shares in Q1 2016, an estimated $169K.
  • Secor Capital Advisors first reported a position in Adverum Biotechnologies in Q1 2015 and held it in 3 quarters.
  • Secor Capital Advisors's Adverum Biotechnologies position peaked at $282K in Q3 2015.
  • 82 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q1 2016.

Based on Secor Capital Advisors's 13F filing for Q1 2016, filed 10 May 2016.